Optimization of Asthma Treatment Through Exhaled NO for Increased Asthma-Related Quality of Life (NOAK)

Karolinska Institutet187 enrolled

Overview

The purpose of this study is to determine whether use of exhaled NO (nitric oxide) to regulate the anti-inflammatory treatment leads to increased asthma-related quality of life in patients with allergic asthma

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

TRIPLE

Enrollment

187

Conditions

Allergic Asthma

Interventions

Single corticosteroid inhalers and SingulairDRUG

Treatment steps according to preset algorithm

Eligibility

Sex: ALLMin age: 18 YearsMax age: 64 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Age 18-64 * Clinical diagnosis of Asthma * Glucocorticoid treatment \> 6 months. * Verified Allergy * Read and speak Swedish Exclusion Criteria: * Smoking * Current regular treatment with long-acting beta2-agonist * Treatment with Singulair only or in combination with glucocorticoids * Taking part in other research study * Pregnancy or breast-feeding * Unstable Asthma

Locations (1)

Runby Primary Health Care Center

Upplands Vasby, Sweden

Outcomes

Primary Outcomes

Mini-AQLQ (Asthma-Related Quality of Life)

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.